|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.0101973
|
|
|
ALPS
|
[NCBI]
|
0.0057725
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00494907
|
|
|
APS2
|
[NCBI]
|
0.0028956
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.00249275
|
|
|
MBP
|
[NCBI]
|
0.00187019
|
|
|
CF
|
[NCBI]
|
0.00152901
|
|
|
RA
|
[NCBI]
|
0.00143036
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00135902
|
|
|
IDDM
|
[NCBI]
|
0.00131144
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
0.00122412
|
|
|
SPS
|
[NCBI]
|
0.00117392
|
|
|
MG
|
[NCBI]
|
0.0011368
|
|
|
IGAD1
|
[NCBI]
|
0.00112974
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.00108731
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000946548
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000721731
|
|
|
TG
|
[NCBI]
|
0.000716645
|
|
|
TNFRSF6
|
[NCBI]
|
0.000716309
|
|
|
TPO
|
[NCBI]
|
0.000675718
|
|
|
AIS3
|
[NCBI]
|
0.000610413
|
|
|
AIS2
|
[NCBI]
|
0.000610413
|
|
|
AD
|
[NCBI]
|
0.000587243
|
|
|
autoimmune disease
|
[NCBI]
|
0.000552049
|
|
|
IDDM18
|
[NCBI]
|
0.000528953
|
|
|
CELIAC6
|
[NCBI]
|
0.000476336
|
|
|
myasthenia, limb-girdle, with tubular aggregates
|
[NCBI]
|
0.000406568
|
|
|
OCP
|
[NCBI]
|
0.000402799
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000381049
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.000340423
|
|
|
dupuytren contracture
|
[NCBI]
|
0.000323725
|
|
|
TNF
|
[NCBI]
|
0.000315155
|
|
|
APS1
|
[NCBI]
|
0.000286922
|
|
|
spondyloenchondrodysplasia
|
[NCBI]
|
0.000282972
|
|
|
FCAS
|
[NCBI]
|
0.000275834
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000261243
|
|
|
IPEX
|
[NCBI]
|
0.000251115
|
|
|
FOXP3
|
[NCBI]
|
0.000247284
|
|
|
WM1
|
[NCBI]
|
0.000242538
|
|
|
AIRE
|
[NCBI]
|
0.000229545
|
|
|
VEGF
|
[NCBI]
|
0.000207949
|
|
|
ALPS2A
|
[NCBI]
|
0.000198781
|
|
|
graves disease
|
[NCBI]
|
0.000191115
|
|
|
CD
|
[NCBI]
|
0.000162071
|
|
|
CEACAM5
|
[NCBI]
|
0.000158264
|
|
|
TNFSF6
|
[NCBI]
|
0.000149219
|
|
|
combined immunodeficiency with autoimmunity and spondylometaphyseal dysplasia
|
[NCBI]
|
0.00013251
|
|
|
PTPN22
|
[NCBI]
|
0.000126218
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000123898
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000117302
|
|
|
IL2RA
|
[NCBI]
|
0.000115677
|
|
|
MPO
|
[NCBI]
|
0.000115163
|
|
|
SAG
|
[NCBI]
|
0.000111773
|
|
|
TNFSF13B
|
[NCBI]
|
0.000111332
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
0.000110657
|
|
|
MC5R
|
[NCBI]
|
0.000106053
|
|
|
KARS
|
[NCBI]
|
0.000106053
|
|
|
CVID
|
[NCBI]
|
0.000102063
|
|
|
MAG
|
[NCBI]
|
9.8034e-05
|
|
|
CTLA4
|
[NCBI]
|
9.77047e-05
|
|
|
NLRP3
|
[NCBI]
|
9.24526e-05
|
|
|
PDCD1
|
[NCBI]
|
9.24526e-05
|
|
|
DSG3
|
[NCBI]
|
9.21381e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
9.18581e-05
|
|
|
VAMAS1
|
[NCBI]
|
8.8113e-05
|
|
|
kabuki syndrome
|
[NCBI]
|
8.75587e-05
|
|
|
EGF
|
[NCBI]
|
8.70275e-05
|
|
|
GAD2
|
[NCBI]
|
7.92001e-05
|
|
|
pernicious anemia
|
[NCBI]
|
7.8783e-05
|
|
|
BST1
|
[NCBI]
|
7.85879e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
7.7178e-05
|
|
|
RP
|
[NCBI]
|
7.29732e-05
|
|
|
PSTPIP1
|
[NCBI]
|
7.27463e-05
|
|
|
anemia, autoimmune hemolytic
|
[NCBI]
|
7.16972e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
7.16972e-05
|
|
|
PTH
|
[NCBI]
|
7.15606e-05
|
|
|
PRF1
|
[NCBI]
|
7.15291e-05
|
|
|
TSHR
|
[NCBI]
|
6.94012e-05
|
|
|
CASP10
|
[NCBI]
|
6.8281e-05
|
|
|
pulmonary nodular lymphoid hyperplasia, familial
|
[NCBI]
|
6.62496e-05
|
|
|
vitiligo, progressive, with mental retardation and urethral duplication
|
[NCBI]
|
6.62496e-05
|
|
|
globulin anomaly involving beta (2a)-globulin
|
[NCBI]
|
6.62496e-05
|
|
|
hyperthyroidism, nonautoimmune
|
[NCBI]
|
6.5993e-05
|
|
|
VIP
|
[NCBI]
|
6.279e-05
|
|
|
AITD3
|
[NCBI]
|
6.12291e-05
|
|
|
ADCYAP1
|
[NCBI]
|
5.95292e-05
|
|
|
DSG1
|
[NCBI]
|
5.72297e-05
|
|
|
IL23A
|
[NCBI]
|
5.66938e-05
|
|
|
AR
|
[NCBI]
|
5.5362e-05
|
|
|
IL17A
|
[NCBI]
|
5.46393e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
5.46393e-05
|
|
|
EXOSC9
|
[NCBI]
|
5.30196e-05
|
|
|
ATP4B
|
[NCBI]
|
5.30196e-05
|
|
|
NLRP2
|
[NCBI]
|
5.30196e-05
|
|
|
g8 protein
|
[NCBI]
|
5.30196e-05
|
|
|
DDX21
|
[NCBI]
|
5.30196e-05
|
|
|
KLRC1
|
[NCBI]
|
5.30196e-05
|
|
|
CD200R1
|
[NCBI]
|
5.30196e-05
|
|
|
C1GALT1C1
|
[NCBI]
|
5.30196e-05
|
|
|
PSMB8
|
[NCBI]
|
5.30196e-05
|
|
|
CD22
|
[NCBI]
|
5.30196e-05
|
|
|
BCL2L11
|
[NCBI]
|
5.30196e-05
|
|
|
DNASE2
|
[NCBI]
|
5.30196e-05
|
|
|
CENPF
|
[NCBI]
|
5.30196e-05
|
|
|
ERVE1
|
[NCBI]
|
5.30196e-05
|
|
|
STX1B
|
[NCBI]
|
5.30196e-05
|
|
|
PSMB9
|
[NCBI]
|
5.30196e-05
|
|
|
GAD3
|
[NCBI]
|
5.30196e-05
|
|
|
TRAF3IP2
|
[NCBI]
|
5.30196e-05
|
|
|
ADAT1
|
[NCBI]
|
5.30196e-05
|
|
|
C1S
|
[NCBI]
|
5.30196e-05
|
|
|
SNRPC
|
[NCBI]
|
5.30196e-05
|
|
|
temporal arteritis
|
[NCBI]
|
5.08154e-05
|
|
|
GBS
|
[NCBI]
|
5.04314e-05
|
|
|
PDGFRB
|
[NCBI]
|
4.95535e-05
|
|
|
AT
|
[NCBI]
|
4.65169e-05
|
|
|
splenomegaly syndrome with splenic germinal center hypoplasia and reduced circulating t-helper cells
|
[NCBI]
|
4.40514e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
4.40514e-05
|
|
|
tn syndrome
|
[NCBI]
|
4.40514e-05
|
|
|
HGF
|
[NCBI]
|
4.39396e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
4.1498e-05
|
|
|
TCRA
|
[NCBI]
|
4.13136e-05
|
|
|
SPP1
|
[NCBI]
|
3.97917e-05
|
|
|
GTS
|
[NCBI]
|
3.95507e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
3.93185e-05
|
|
|
EXOSC10
|
[NCBI]
|
3.9287e-05
|
|
|
NLRP1
|
[NCBI]
|
3.9287e-05
|
|
|
CD72
|
[NCBI]
|
3.9287e-05
|
|
|
RORC
|
[NCBI]
|
3.9287e-05
|
|
|
PTPN12
|
[NCBI]
|
3.9287e-05
|
|
|
CEP2
|
[NCBI]
|
3.9287e-05
|
|
|
CCNG1
|
[NCBI]
|
3.9287e-05
|
|
|
CD5
|
[NCBI]
|
3.9287e-05
|
|
|
CARD8
|
[NCBI]
|
3.9287e-05
|
|
|
MAN2A1
|
[NCBI]
|
3.9287e-05
|
|
|
AARS
|
[NCBI]
|
3.9287e-05
|
|
|
ZFAT1
|
[NCBI]
|
3.9287e-05
|
|
|
TNFRSF17
|
[NCBI]
|
3.9287e-05
|
|
|
SH2D2A
|
[NCBI]
|
3.9287e-05
|
|
|
FCGR3B
|
[NCBI]
|
3.9287e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
3.6806e-05
|
|
|
COL2A1
|
[NCBI]
|
3.66367e-05
|
|
|
PARG
|
[NCBI]
|
3.6382e-05
|
|
|
hyperimmunoglobulin g1(a1) syndrome
|
[NCBI]
|
3.58436e-05
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
3.58436e-05
|
|
|
myasthenia, limb-girdle, autoimmune
|
[NCBI]
|
3.58436e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
3.58436e-05
|
|
|
FCGRT
|
[NCBI]
|
3.41336e-05
|
|
|
VSIG4
|
[NCBI]
|
3.41336e-05
|
|
|
SECISBP2
|
[NCBI]
|
3.41336e-05
|
|
|
RNU1
|
[NCBI]
|
3.41336e-05
|
|
|
BHLHB2
|
[NCBI]
|
3.41336e-05
|
|
|
GPR132
|
[NCBI]
|
3.41336e-05
|
|
|
TYRO3
|
[NCBI]
|
3.41336e-05
|
|
|
SPHK2
|
[NCBI]
|
3.41336e-05
|
|
|
LYN
|
[NCBI]
|
3.41336e-05
|
|
|
HRH1
|
[NCBI]
|
3.41336e-05
|
|
|
AFP
|
[NCBI]
|
3.15668e-05
|
|
|
ICA1
|
[NCBI]
|
3.08038e-05
|
|
|
IL22
|
[NCBI]
|
3.08038e-05
|
|
|
AKAP12
|
[NCBI]
|
3.08038e-05
|
|
|
PTPN6
|
[NCBI]
|
3.08038e-05
|
|
|
TNFSF13
|
[NCBI]
|
3.08038e-05
|
|
|
LMOD1
|
[NCBI]
|
3.08038e-05
|
|
|
NOVA1
|
[NCBI]
|
3.08038e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
3.08038e-05
|
|
|
RPL7
|
[NCBI]
|
3.08038e-05
|
|
|
BAK1
|
[NCBI]
|
3.08038e-05
|
|
|
GRM1
|
[NCBI]
|
3.08038e-05
|
|
|
thymoma, familial
|
[NCBI]
|
3.06098e-05
|
|
|
buerger disease
|
[NCBI]
|
3.06098e-05
|
|
|
roifman syndrome
|
[NCBI]
|
3.06098e-05
|
|
|
satoyoshi syndrome
|
[NCBI]
|
3.06098e-05
|
|
|
JAK3
|
[NCBI]
|
2.94107e-05
|
|
|
NPY
|
[NCBI]
|
2.89692e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.89422e-05
|
|
|
DCC
|
[NCBI]
|
2.84867e-05
|
|
|
RCC1
|
[NCBI]
|
2.83401e-05
|
|
|
EEA1
|
[NCBI]
|
2.83401e-05
|
|
|
CDR1
|
[NCBI]
|
2.83401e-05
|
|
|
RCV1
|
[NCBI]
|
2.83401e-05
|
|
|
AMPH
|
[NCBI]
|
2.83401e-05
|
|
|
AXL
|
[NCBI]
|
2.83401e-05
|
|
|
LAG5
|
[NCBI]
|
2.83401e-05
|
|
|
MATN1
|
[NCBI]
|
2.83401e-05
|
|
|
MFGE8
|
[NCBI]
|
2.83401e-05
|
|
|
DSC3
|
[NCBI]
|
2.83401e-05
|
|
|
BDNF
|
[NCBI]
|
2.81127e-05
|
|
|
IL2
|
[NCBI]
|
2.74097e-05
|
|
|
calcific aortic disease with immunologic abnormalities, familial
|
[NCBI]
|
2.67882e-05
|
|
|
IDDM12
|
[NCBI]
|
2.67882e-05
|
|
|
PYCARD
|
[NCBI]
|
2.63866e-05
|
|
|
PTPRN
|
[NCBI]
|
2.63866e-05
|
|
|
TPR
|
[NCBI]
|
2.63866e-05
|
|
|
RMD
|
[NCBI]
|
2.58431e-05
|
|
|
CLU
|
[NCBI]
|
2.56159e-05
|
|
|
ALD
|
[NCBI]
|
2.55233e-05
|
|
|
PXE
|
[NCBI]
|
2.48486e-05
|
|
|
NFE2L2
|
[NCBI]
|
2.47701e-05
|
|
|
ICOS
|
[NCBI]
|
2.47701e-05
|
|
|
TLR9
|
[NCBI]
|
2.45296e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
2.37986e-05
|
|
|
AVP
|
[NCBI]
|
2.35794e-05
|
|
|
GPT
|
[NCBI]
|
2.35151e-05
|
|
|
MID1
|
[NCBI]
|
2.33932e-05
|
|
|
PRTN3
|
[NCBI]
|
2.33932e-05
|
|
|
TNFSF10
|
[NCBI]
|
2.33666e-05
|
|
|
PDCD4
|
[NCBI]
|
2.21954e-05
|
|
|
MHC2TA
|
[NCBI]
|
2.21954e-05
|
|
|
MERTK
|
[NCBI]
|
2.21954e-05
|
|
|
CD40
|
[NCBI]
|
2.21954e-05
|
|
|
TRAF6
|
[NCBI]
|
2.21954e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.21954e-05
|
|
|
VRNI
|
[NCBI]
|
2.21273e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
2.19402e-05
|
|
|
CINCA
|
[NCBI]
|
2.13587e-05
|
|
|
MBL2
|
[NCBI]
|
2.12346e-05
|
|
|
C9
|
[NCBI]
|
2.11367e-05
|
|
|
GZMA
|
[NCBI]
|
2.11367e-05
|
|
|
ADRB1
|
[NCBI]
|
2.11367e-05
|
|
|
RPS6
|
[NCBI]
|
2.11367e-05
|
|
|
STAT1
|
[NCBI]
|
2.08286e-05
|
|
|
GAD1
|
[NCBI]
|
2.0189e-05
|
|
|
TNFRSF14
|
[NCBI]
|
2.0189e-05
|
|
|
CASP1
|
[NCBI]
|
2.0189e-05
|
|
|
ACHE
|
[NCBI]
|
1.95641e-05
|
|
|
FMF
|
[NCBI]
|
1.93672e-05
|
|
|
LAT
|
[NCBI]
|
1.93321e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.93321e-05
|
|
|
MOG
|
[NCBI]
|
1.93321e-05
|
|
|
CAMP
|
[NCBI]
|
1.85508e-05
|
|
|
STAT5B
|
[NCBI]
|
1.85508e-05
|
|
|
CCL18
|
[NCBI]
|
1.78335e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
1.78335e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.78335e-05
|
|
|
VDR
|
[NCBI]
|
1.76752e-05
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
1.75522e-05
|
|
|
atransferrinemia
|
[NCBI]
|
1.75522e-05
|
|
|
STAT4
|
[NCBI]
|
1.71709e-05
|
|
|
LPL
|
[NCBI]
|
1.66498e-05
|
|
|
PRL
|
[NCBI]
|
1.60733e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
1.60218e-05
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
1.60218e-05
|
|
|
SEDC
|
[NCBI]
|
1.59844e-05
|
|
|
DSP
|
[NCBI]
|
1.59821e-05
|
|
|
IGKC
|
[NCBI]
|
1.59821e-05
|
|
|
NCF1
|
[NCBI]
|
1.59821e-05
|
|
|
DGS
|
[NCBI]
|
1.54485e-05
|
|
|
IL1RN
|
[NCBI]
|
1.54451e-05
|
|
|
NRAS
|
[NCBI]
|
1.54451e-05
|
|
|
CTSK
|
[NCBI]
|
1.54451e-05
|
|
|
C4A
|
[NCBI]
|
1.54451e-05
|
|
|
MAPK14
|
[NCBI]
|
1.54451e-05
|
|
|
PTPRC
|
[NCBI]
|
1.49406e-05
|
|
|
NOS2A
|
[NCBI]
|
1.49406e-05
|
|
|
G6PC2
|
[NCBI]
|
1.44653e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
1.44653e-05
|
|
|
BAX
|
[NCBI]
|
1.44653e-05
|
|
|
ADAMTS13
|
[NCBI]
|
1.40161e-05
|
|
|
MVK
|
[NCBI]
|
1.40161e-05
|
|
|
ZFP36
|
[NCBI]
|
1.35906e-05
|
|
|
EPO
|
[NCBI]
|
1.34017e-05
|
|
|
IFNG
|
[NCBI]
|
1.28024e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.24398e-05
|
|
|
IL12B
|
[NCBI]
|
1.24361e-05
|
|
|
SNDI
|
[NCBI]
|
1.23932e-05
|
|
|
CMD1A
|
[NCBI]
|
1.21432e-05
|
|
|
PSORS1
|
[NCBI]
|
1.18322e-05
|
|
|
DYT1
|
[NCBI]
|
1.14319e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.14319e-05
|
|
|
TFRC
|
[NCBI]
|
1.14319e-05
|
|
|
MICA
|
[NCBI]
|
1.14319e-05
|
|
|
PF4
|
[NCBI]
|
1.12702e-05
|
|
|
F3
|
[NCBI]
|
1.11872e-05
|
|
|
COL4A3
|
[NCBI]
|
1.11249e-05
|
|
|
HLA-A
|
[NCBI]
|
1.08301e-05
|
|
|
PPIA
|
[NCBI]
|
1.08301e-05
|
|
|
COL17A1
|
[NCBI]
|
1.05468e-05
|
|
|
IL18
|
[NCBI]
|
1.05468e-05
|
|
|
HRG
|
[NCBI]
|
1.02741e-05
|
|
|
THPO
|
[NCBI]
|
1.02741e-05
|
|
|
CMH
|
[NCBI]
|
1.01285e-05
|
|
|
CHNG1
|
[NCBI]
|
9.7281e-06
|
|
|
DRD2
|
[NCBI]
|
9.51397e-06
|
|
|
NP
|
[NCBI]
|
9.51397e-06
|
|
|
CHAT
|
[NCBI]
|
9.37429e-06
|
|
|
AGER
|
[NCBI]
|
9.3735e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
8.98876e-06
|
|
|
SLC26A4
|
[NCBI]
|
8.82926e-06
|
|
|
myeloma, multiple
|
[NCBI]
|
8.30914e-06
|
|
|
APCS
|
[NCBI]
|
8.2084e-06
|
|
|
LPG
|
[NCBI]
|
7.68258e-06
|
|
|
CAT
|
[NCBI]
|
7.07683e-06
|
|
|
RNASE3
|
[NCBI]
|
6.83993e-06
|
|
|
GFAP
|
[NCBI]
|
6.66473e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
6.49546e-06
|
|
|
HAE
|
[NCBI]
|
6.27645e-06
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
6.06941e-06
|
|
|
LIPC
|
[NCBI]
|
6.06602e-06
|
|
|
PSEN2
|
[NCBI]
|
5.93001e-06
|
|
|
CCL22
|
[NCBI]
|
5.93001e-06
|
|
|
ADA
|
[NCBI]
|
5.76637e-06
|
|
|
GPI
|
[NCBI]
|
5.62565e-06
|
|
|
PTHLH
|
[NCBI]
|
5.47826e-06
|
|
|
STAT5A
|
[NCBI]
|
5.41825e-06
|
|
|
SLC4A1
|
[NCBI]
|
5.41825e-06
|
|
|
IL4
|
[NCBI]
|
5.41825e-06
|
|
|
HIDS
|
[NCBI]
|
5.1763e-06
|
|
|
CCL17
|
[NCBI]
|
4.84338e-06
|
|
|
ASS
|
[NCBI]
|
4.23436e-06
|
|
|
ESR1
|
[NCBI]
|
4.23436e-06
|
|
|
LSA
|
[NCBI]
|
4.14331e-06
|
|
|
INS
|
[NCBI]
|
3.82471e-06
|
|
|
PPH1
|
[NCBI]
|
3.72598e-06
|
|
|
NGFB
|
[NCBI]
|
3.55506e-06
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
3.42143e-06
|
|
|
IGFALS
|
[NCBI]
|
3.37888e-06
|
|
|
MS
|
[NCBI]
|
3.31919e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
3.2317e-06
|
|
|
CRH
|
[NCBI]
|
3.15528e-06
|
|
|
SLPI
|
[NCBI]
|
2.87663e-06
|
|
|
DYX1
|
[NCBI]
|
2.87095e-06
|
|
|
IBD1
|
[NCBI]
|
2.73285e-06
|
|
|
AHO
|
[NCBI]
|
2.65271e-06
|
|
|
PNKD1
|
[NCBI]
|
2.39035e-06
|
|
|
PG
|
[NCBI]
|
2.38206e-06
|
|
|
SOD2
|
[NCBI]
|
2.21659e-06
|
|
|
NRCLP1
|
[NCBI]
|
2.17358e-06
|
|
|
SERPINA6
|
[NCBI]
|
1.959e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
1.82897e-06
|
|
|
CLL
|
[NCBI]
|
1.78261e-06
|
|
|
SDS
|
[NCBI]
|
1.71699e-06
|
|
|
HIGM1
|
[NCBI]
|
1.44318e-06
|
|
|
SPDA1
|
[NCBI]
|
1.44318e-06
|
|
|
CNTF
|
[NCBI]
|
1.33205e-06
|
|
|
KRT20
|
[NCBI]
|
1.25125e-06
|
|
|
POMC
|
[NCBI]
|
1.18877e-06
|
|
|
CASR
|
[NCBI]
|
1.18246e-06
|
|
|
BGLAP
|
[NCBI]
|
1.14908e-06
|
|
|
IL6
|
[NCBI]
|
1.0843e-06
|
|
|
LIP
|
[NCBI]
|
1.01921e-06
|
|
|
IFNA1
|
[NCBI]
|
9.62363e-07
|
|
|
TLR2
|
[NCBI]
|
9.05046e-07
|
|
|
HHC1
|
[NCBI]
|
8.98362e-07
|
|
|
PTEN
|
[NCBI]
|
7.97353e-07
|
|
|
PSEN1
|
[NCBI]
|
5.86463e-07
|
|
|
CMTC
|
[NCBI]
|
5.04917e-07
|
|
|
PEDF
|
[NCBI]
|
3.81484e-07
|
|
|
SPINK1
|
[NCBI]
|
3.65464e-07
|
|
|
PI
|
[NCBI]
|
3.42089e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.17953e-07
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.28547e-07
|
|
|
giant platelet syndrome
|
[NCBI]
|
2.14602e-07
|
|
|
AMC
|
[NCBI]
|
1.88837e-07
|
|
|
ACPP
|
[NCBI]
|
1.05572e-07
|
|
|
CRMO
|
[NCBI]
|
6.56339e-08
|
|
|
CP
|
[NCBI]
|
3.56212e-08
|
|
|
WAS
|
[NCBI]
|
3.19571e-08
|
|
|
FGF7
|
[NCBI]
|
3.18622e-08
|
|
|
RTS
|
[NCBI]
|
3.02128e-08
|
|